Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
mutual funds
iti pharma and healthcare fund direct growth
ITI Pharma and Healthcare Fund Direct Growth

ITI Pharma and Healthcare Fund Direct Growth

  • Very High Risk
  • Equity
  • Sector - Healthcare
Share
  • Whatsapp
  • Twitter
  • Facebook
NAV as on May 5, 2025
i
Price per unit of the scheme.
₹ 17.16371.18%1 Day Change
5.09%
Minimum Investment₹5000
Expense Ratio0.43%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.
*Morningstar Rating Methodologyi
i

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions
 

bt_logoFUND PERFORMANCE

As On Jan 01, 2023
Compare fund’s performance against category average across different time periods


No Data Found.
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

bt_logoFUND COMPARISON

1M3M6M1Y3Y5Y
This Fund
ITI Pharma and Healthcare Fund Direct Growth
VS
Equity: Sector - Healthcare Average NAV
    Topper in Equity: Sector - Healthcare
    All Fund


    No Data Found.
    *For the other fund, rescaled NAVs are used
    Share
    • Whatsapp
    • Twitter
    • Facebook

    bt_logoRETURN CALCULATOR

    Check the return on your investment in the fund
    ITI Pharma and Healthcare Fund Direct Growth
    Investment Type
    Monthly Investment
    Time Period (yrs)
    Annual Return in %
    • Invested Amount
      ₹0
    • Return
      ₹0
    • Current Value
      ₹0

    bt_logoFUND SUMMARY

    Benchmark
    Nifty Healthcare TR INR
    Expense Ratio
    0.43%
    Category Avg Expense Ratio
    1.00%
    Minimum Investment (Lumpsum/SIP)
    ₹ 5000 /₹ 1000
    Lock In (Years)
    No Lock-in
    Fund Size
    ₹ 213.78 Cr(As on Mar, 2025)
    Inception Date
    Nov 11, 2021
    Turnover
    - %
    Exit Load
    1% - If redeemed or switched out on or before completion of 12 months from the date of allotment of units. Nil - If redeemed or switched out after completion of 12 months from the date of allotment of units.

    bt_logoABOUT THE FUND

    Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

    ITI Pharma and Healthcare Fund Direct Growth is an Equity - Sector - Healthcare fund. The fund was launched inNov 11, 2021. Its risk level is . The NAV of the fund as onMay 05, 2025 is ₹17.16. Its expense ratio is 0.43 %. The fund has an AUM of ₹213.78 Cr.The fund is managed byDhimant Shah,Rohan Korde,Tanay Gabhawala.
    The minimum initial investment is  ₹5000 in Lumpsum mode.

    SUBSCRIBE TO
    BUSINESS TODAY MAGAZINE
    Subscribe Now
    Already a subscriber?Login

    bt_logoFUND MANAGER

    Rohan Korde
    Rohan Korde
    i
    Lead Fund Manager.
    Nov 11, 2021 - Present
    • Fund Manager Rank5Out of 10
      i
      Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
    • Schemes managed12
    • Total AUM₹ 7,654.54 Cr
    • Highest Return In 1 Yr19.15 %
    Other Funds
    • table
    • card
    1M
    3M
    6M
    1Y
    3Y
    5Y
    Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
    ITI Pharma and Healthcare Fund Direct Growth
    --
    ₹ 17.16
    5.09%
    2.30%
    Very High Risk
    ₹213.78Cr
    ITI Large Cap Fund Direct Growth
    --
    ₹ 18.52
    5.08%
    3.75%
    Very High Risk
    ₹472.57Cr
    ITI Value Fund Direct Growth
    --
    ₹ 16.85
    5.36%
    2.32%
    Very High Risk
    ₹297.69Cr
    ITI Pharma and Healthcare Fund Direct Growth
    Very High Risk--
    • NAV₹ 17.16
    • Fund Size₹213.78Cr
    Fund Return5.09%
    Category Return2.30%
    ITI Large Cap Fund Direct Growth
    Very High Risk--
    • NAV₹ 18.52
    • Fund Size₹472.57Cr
    Fund Return5.08%
    Category Return3.75%
    ITI Value Fund Direct Growth
    Very High Risk--
    • NAV₹ 16.85
    • Fund Size₹297.69Cr
    Fund Return5.36%
    Category Return2.32%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
    Dhimant Shah
    Dhimant Shah
    i
    Lead Fund Manager.
    Dec 1, 2022 - Present
    • Schemes managed11
    • Total AUM₹ 7,696.79 Cr
    • Highest Return In 1 Yr19.15 %
    Other Funds
    • table
    • card
    1M
    3M
    6M
    1Y
    3Y
    5Y
    Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
    ITI Pharma and Healthcare Fund Direct Growth
    --
    ₹ 17.16
    5.09%
    2.30%
    Very High Risk
    ₹213.78Cr
    ITI Large Cap Fund Direct Growth
    --
    ₹ 18.52
    5.08%
    3.75%
    Very High Risk
    ₹472.57Cr
    ITI Value Fund Direct Growth
    --
    ₹ 16.85
    5.36%
    2.32%
    Very High Risk
    ₹297.69Cr
    ITI Pharma and Healthcare Fund Direct Growth
    Very High Risk--
    • NAV₹ 17.16
    • Fund Size₹213.78Cr
    Fund Return5.09%
    Category Return2.30%
    ITI Large Cap Fund Direct Growth
    Very High Risk--
    • NAV₹ 18.52
    • Fund Size₹472.57Cr
    Fund Return5.08%
    Category Return3.75%
    ITI Value Fund Direct Growth
    Very High Risk--
    • NAV₹ 16.85
    • Fund Size₹297.69Cr
    Fund Return5.36%
    Category Return2.32%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
    Tanay Gabhawala
    Tanay Gabhawala
    i
    Lead Fund Manager.
    Oct 21, 2022 - Present
    • Schemes managed10
    • Total AUM₹ 7,592.06 Cr
    • Highest Return In 1 Yr19.15 %
    Other Funds
    • table
    • card
    1M
    3M
    6M
    1Y
    3Y
    5Y
    Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
    ITI Pharma and Healthcare Fund Direct Growth
    --
    ₹ 17.16
    5.09%
    2.30%
    Very High Risk
    ₹213.78Cr
    ITI Value Fund Direct Growth
    --
    ₹ 16.85
    5.36%
    2.32%
    Very High Risk
    ₹297.69Cr
    ITI Banking and Financial Services Fund Direct Growth
    --
    ₹ 15.65
    5.31%
    5.93%
    Very High Risk
    ₹287.76Cr
    ITI Pharma and Healthcare Fund Direct Growth
    Very High Risk--
    • NAV₹ 17.16
    • Fund Size₹213.78Cr
    Fund Return5.09%
    Category Return2.30%
    ITI Value Fund Direct Growth
    Very High Risk--
    • NAV₹ 16.85
    • Fund Size₹297.69Cr
    Fund Return5.36%
    Category Return2.32%
    ITI Banking and Financial Services Fund Direct Growth
    Very High Risk--
    • NAV₹ 15.65
    • Fund Size₹287.76Cr
    Fund Return5.31%
    Category Return5.93%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

    bt_logoDETAILED PORTFOLIO

    As on Mar, 2025
    EQUITY (97.95%)
    DEBT (-%)
    CASH (2.05%)
    Allocation by Market Cap
    Large Cap(29.24%)
    Mid Cap(33.78%)
    Small Cap(31.63%)
    Industry Holdings
    • Drug Manufacturers Specialty Generic70.47%
    • Medical Care18.44%
    • Biotechnology2.86%
    • Agricultural Inputs2.58%
    • Diagnostics Research2.21%
    • Drug Manufacturers Major1.45%
    Stock Holdings
    • Sun Pharmaceuticals Industries Ltd16.22%
    • Divi's Laboratories Ltd5.96%
    • Lupin Ltd5.78%
    • Suven Pharmaceuticals Ltd5.39%
    • Apollo Hospitals Enterprise Ltd5.16%
    • Max Healthcare Institute Ltd Ordinary Shares5.07%

    bt_logoPERFORMANCE MEASURES

    Fund evaluation across critical parameters for better decision making. Study period is 3 years.
    • Consistency
      i
      It represents the consistency of a fund in beating its benchmark.
    • Downside Risk
      i
      Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
    • Risk Adjusted Return
      i
      Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
    • Volatility
      i
      Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
    • Upside Capture Ratio
      i
      Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
    • Downside Capture Ratio
      i
      Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.

    bt_logoHISTORICAL RISK MEASURES

    Statistical measures to evaluate mutual fund risk. All ratios are calculated for a three-year time duration.
    • Alpha: Excess return of the fund over benchmark
      i
      Any Alpha above zero is considered good. However, for comparison, a fund with a higher Alpha is considered better. Alpha is normally used in conjunction with Beta. If the Beta is high, it implies that the fund manager took a high risk to generate Alpha.
      1.56
      This Fund
      VS
      0.58
      Category Avg
    • R-Squared: How well the fund tracks benchmark
      i
      R-Squared measures the correlation of fund returns and its benchmark returns. It varies between 0 and 1. The metric, Beta makes no sense if R-Squared is equal to zero. Thus, both Beta and R-Squared should be used in conjunction. A fund with a high R-Squared and low Beta is considered a less risky fund.
      96.37
      This Fund
      VS
      94.87
      Category Avg
    • Beta: Risk of the fund in relation to benchmark
      i
      Beta >1 indicates that the fund is more volatile than its benchmark while Beta < 1 indicates that the fund is less volatile than its benchmark. The Beta of the benchmark is equal to 1.
      0.94
      This Fund
      VS
      0.95
      Category Avg
    • Sharpe Ratio: Risk adjusted return of the fund
      i
      Sharpe Ratio is a measure of return per unit of risk. A higher Sharpe ratio indicates better risk adjusted return given by the fund.
      0.87
      This Fund
      VS
      0.81
      Category Avg
    • Sortino Ratio: Return per unit of bad risk
      i
      A variation of Sharpe ratio, Sortino considers only the downside risk. Unlike Sharpe ratio which considers both good risk and bad risk, Sortino factors only the bad risk. A high Sortino ratio indicates better return for each unit of downside risk.
      1.44
      This Fund
      VS
      1.39
      Category Avg
    • Standard Devation: Volatility of the fund
      i
      Standard deviation is a measure of dispersion of fund returns from its average return. A fund with a higher Standard deviation is more volatile than a fund with a low standard deviation.
      16.38
      This Fund
      VS
      16.73
      Category Avg
    Benchmark used in calculation : S&P BSE 500 India TR INR

    bt_logoPEER ANALYSIS

    1M
    3M
    6M
    1Y
    3Y
    5Y
    • card
    • table
    Fund NameMorningstar RatingNAV Fund Return Category ReturnRisk Fund Size
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

    bt_logoTOP FUNDS FROM THIS AMC

    1M
    3M
    6M
    1Y
    3Y
    5Y
    • card
    • table
    Fund NameMorningstar RatingNAV Fund Return Category Return Risk Fund Size (Cr)
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

    bt_logoABOUT THE AMC

    company icon
    ITI Asset Management Limited
    ITI Asset Management Limited manages assets worth ₹ 9,298.34 crores. It’s current offering of mutual fund schemes includes 12 equity, 3 debt and 2 hybrid schemes.
    phone icon
    Phone
    022-66214999
    mail icon
    Email
    mfassist@itiorg.com
    aum
    AUM
    ₹ 9,298.34 Cr (
    As on Mar 31, 2025
    )
    location
    Address
    Naman Midtown “A” Wing, 21st Floor, Senapati Bapat Marg, Elphinstone Road Mumbai,400013

    bt_logoFAQ's

    What is the category of ITI Pharma and Healthcare Fund Direct Growth ?
    The category of ITI Pharma and Healthcare Fund Direct Growth is Equity - Sector - Healthcare
    What is the current NAV of ITI Pharma and Healthcare Fund Direct Growth ?
    The current NAV of ITI Pharma and Healthcare Fund Direct Growth as on May 05, 2025 is ₹17.16
    How safe is ITI Pharma and Healthcare Fund Direct Growth ?
    The risk level of ITI Pharma and Healthcare Fund Direct Growth is Very High.
    What are short term returns given by ITI Pharma and Healthcare Fund Direct Growth ?
    The return given by ITI Pharma and Healthcare Fund Direct Growth in 1 month is 5.09%, 3 months is -1.64%, 6 months is -4.92%, and 1 year is 19.15%
    What are the long term returns given by ITI Pharma and Healthcare Fund Direct Growth ?
    The return given by ITI Pharma and Healthcare Fund Direct Growth in 3 years is 22.70% and 5 years is --.
    What is the expense ratio of ITI Pharma and Healthcare Fund Direct Growth ?
    The expense ratio of ITI Pharma and Healthcare Fund Direct Growth is 0.43%
    What is the AUM of ITI Pharma and Healthcare Fund Direct Growth ?
    The assets under Management (AUM) of ITI Pharma and Healthcare Fund Direct Growth is Rs 213.78 crores.
    What is the minimum investment in ITI Pharma and Healthcare Fund Direct Growth ?
    The minimum Lumpsum investment in ITI Pharma and Healthcare Fund Direct Growth is ₹5,000.00 and the minimum SIP investment in ITI Pharma and Healthcare Fund Direct Growth is ₹1,000.00
    What is the asset allocation of ITI Pharma and Healthcare Fund Direct Growth?
    ITI Pharma and Healthcare Fund Direct Growth has an exposure of 97.95% in Equity and 2.05% in Cash & Money Market Securities

    bt_logoCALCULATORS

    calculatorIncome Tax Calculatorsip calculatorSIP Calculatorfd calculatorFD Calculatordividend yield calculatorDividend Yield Calculatorlump sum calculatorLump-Sum Calculatorcagr calculator CAGR Calculatortop up sip calculatorTop-Up Calculatorlatter factor calculatorLatte Factor Calculator

    bt_logoTop Stories